Abstract:Graphical and Lay Summary This paper introduces a novel pump‐free, high‐throughput organ‐on‐a‐chip platform compatible with automation for large‐scale applications. Utilizing this platform, a gut‐on‐a‐chip model was successfully developed and employed in the evaluation of drug intestinal absorption. The versatility of this platform in simulating various physiological systems suggests its significant potential as a valuable tool for advancing drug development. Organ‐on‐a‐chip technology has shown great potential in disease modeling and drug evaluation. However, traditional organ‐on‐a‐chip devices are mostly pump‐dependent with low throughput, which makes it difficult to leverage their advantages. In this study, we have developed a generic, pump‐free organ‐on‐a‐chip platform consisting of a 32‐unit chip and an adjustable rocker, facilitating high‐throughput dynamic cell culture with straightforward operation. By utilizing the rocker to induce periodic fluid forces, we can achieve fluidic conditions similar to those obtained with traditional pump‐based systems. Through constructing a gut‐on‐a‐chip model, we observed remarkable enhancements in the expression of barrier‐associated proteins and the spatial distribution of differentiated intestinal cells compared to static culture. Furthermore, RNA sequencing analysis unveiled enriched pathways associated with cell proliferation, lipid transport, and drug metabolism, indicating the ability of the platform to mimic critical physiological processes. Additionally, we tested seven drugs that represent a range of high, medium, and low in vivo permeability using this model and found a strong correlation between their Papp values and human Fa, demonstrating the capability of this model for drug absorption evaluation. Our findings highlight the potential of this pump‐free organ‐on‐a‐chip platform as a valuable tool for advancing drug development and enabling personalized medicine.

Drug absorption related nephrotoxicity assessment on an intestine-kidney chip

Efficient Drug Screening and Nephrotoxicity Assessment on Co-culture Microfluidic Kidney Chip

Duodenum Intestine-Chip for preclinical drug assessment in a human relevant model

An on-chip intestine-liver model for multiple drugs absorption and metabolism behavior simulation

Pharmacokinetic and pharmacodynamic insights from microfluidic intestine-on-a-chip models

Validation of a Caco-2 microfluidic Chip model for predicting intestinal absorption of BCS Class I-IV drugs

A nephron model for study of drug-induced acute kidney injury and assessment of drug-induced nephrotoxicity

A Three-Dimensional (3D) Liver-Kidney on a Chip with a Biomimicking Circulating System for Drug Safety Evaluation.

Functional Evaluation and Nephrotoxicity Assessment of Human Renal Proximal Tubule Cells on a Chip

Organoid-derived Duodenum Intestine-Chip for preclinical drug assessment in a human relevant system

Drug evaluations using a novel microphysiometer based on cell-based biosensors

A murine ex vivo 3D kidney proximal tubule model predicts clinical drug-induced nephrotoxicity

A generic pump‐free organ‐on‐a‐chip platform for assessment of intestinal drug absorption

Development of novel tools for the in vitro investigation of drug-induced liver injury

Emerging microfluidic gut-on-a-chip systems for drug development

Hepatotoxic assessment in a microphysiological system: Simulation of the drug absorption and toxic process after an overdosed acetaminophen on intestinal-liver-on-chip

A Biomimetic Human Gut‐on‐a‐Chip for Modeling Drug Metabolism in Intestine

Investigation of absorption, metabolism and toxicity of ginsenosides compound K based on human organ chips

Drug Toxicity Evaluation Based on Organ-on-a-chip Technology: A Review

Intestine‐on‐a‐chip for Intestinal Disease Study and Pharmacological Research